<div class="container">

<table style="width: 100%;"><tr>
<td>hbim-internal</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Internal functions not be to called directly</h2>

<h3>Description</h3>

<p> These are functions that are called by the <code>hbrr</code> and <code>hbpp</code> 
functions. They integrate 1, 2 or 3 component models or integrate by simulation. Special functions 
ending in .rhoeq1 are for when rho equals 1.</p>


<h3>Usage</h3>

<pre><code class="language-R">hbpp.integrate1(MU, V, A = 1, RP = 0.1, ...)
hbpp.integrate2(MU, V, A = c(1, 1), RP = 0.1, ...)
hbpp.integrate3(MU, V, A = c(1, 1, 1),RP=0.1, ...)
hbpp.simulate(MU, V, A, RP = 0.1, NSIM = 10^5)
hbrr.integrate1(MU, V, A = 1, ...)
hbrr.integrate2(MU, V, A = c(1, 1), ...)
hbrr.integrate2.rhoeq1(MU, V, A = c(1, 1), ...)
hbrr.integrate3(MU, V, A = c(1, 1, 1), ...)
hbrr.integrate3.rhoeq1(MU, V, A = c(1, 1, 1), ...)
hbrr.simulate(MU, V, A, NSIM = 10^4)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>MU</code></td>
<td>
<p>mean vector of the log10 dose</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>V</code></td>
<td>
<p>variance matrix of the log10 dose</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>A</code></td>
<td>
<p>vector of slope parameters in the Hill model, one for each component</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>NSIM</code></td>
<td>
<p>number of simulations</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>RP</code></td>
<td>
<p>protection bound, an individual is protected if relative risk is greater than RP</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>...</code></td>
<td>
<p>additional parameters to pass to the <code>integrate</code> function</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>a numeric value of the expected relative risk or percent protected.</p>


<h3>Author(s)</h3>

<p>M.P. Fay</p>


<h3>References</h3>

<p> Saul A, Fay MP (2007).  Human Immunity and the Design of Multi-Component, Single Target Vaccines. PLoS ONE 2(9): e850. doi:10.1371/jounal.pone.0000850
</p>


</div>